We are international
Donate
• health professionals TEXT SIZE   
clinical trials    back

ASH 2011: Dr. Popat - An Alternate Day Dosing Strategy for Lenalidomide in Multiple Myeloma Improves Cost-Effectiveness Whilst Maintaining Efficacy
Rakesh Popat, MD
UCL Cancer Institute
London, United Kingdom
12.07.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles